President Trump signed Executive Order 14401, directing the FDA to fast-track review of psychedelic compounds and cutting the standard ten-to-twelve-month review down to as little as one to two months via “National Priority Vouchers.”
In 1970, Tom Forçade put a pie in a federal commissioner’s face. When the government…
Thailand is moving closer to putting its medical-only cannabis model into national law, with a…
Cannabis use among U.S. teens has declined substantially even as adult-use legalization has expanded, challenging…
An Australian company says its THC-free tablet could become the world’s first registered prescription CBD…
That's how many marijuana arrests American police reported between 1990 and 2025, according to FBI-derived…
For decades, the Netherlands has lived with a long-standing contradiction known as the “backdoor problem”:…